iGATE Clinical Research International (iGATE CRI), the clinical research arm of the $300-million iGATE Corp, US, plans to double its scientific and clinical investigators team in India. | |
| The company will double its workforce to 120 by this year and will invest around Rs 10 crore for the expansion of laboratory facilities and related infrastructure in Mumbai. |
| |
| iGATE's expansion signifies the growing potential of India as a preferred location for global clinical studies especially for multinational drug companies. |
| |
| Vasudeo Ginde, MD, iGATE CRI, said the current investment is part of an ongoing business expansion plan of the group. |
| |
|
| |
